Review, 2024

Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer

ANNALS OF ONCOLOGY, ISSN 0923-7534, Volume 35, 5, Pages 414-428, 10.1016/j.annonc.2024.02.006

Contributors

Bogani, Giorgio 0000-0001-8373-8569 (Corresponding author) [1] Monk, Bradley J. [2] Powell, M. A. [3] Westin, S. N. [4] [5] Slomovitz, Brian [6] Moore, K. N. [7] [8] Eskander, Ramez [9] [10] Raspagliesi, F. [1] Barretina-Ginesta, M. P. [11] [12] [13] [14] Colombo, N. [15] [16] Mirza, Mansoor Raza 0000-0002-8085-1010 [1] [3] [17] [18] [19]

Affiliations

  1. [1] Fdn IRCCS Ist Nazl Tumori Milano, Gynecol Oncol Unit, Milan, Italy
    2. [NORA names: Italy; Europe, EU; OECD];
  2. [2] GOG Fdn, Florida Canc Specialists & Res Inst, W Palm Beach, FL USA
    3. [NORA names: United States; America, North; OECD];
  3. [3] Washington Univ, Sch Med, Div Gynecol Oncol, St Louis, MO USA
    4. [NORA names: United States; America, North; OECD];
  4. [4] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
    5. [NORA names: United States; America, North; OECD];
  5. [5] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
    6. [NORA names: United States; America, North; OECD];

Abstract

Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.

Keywords

chemotherapy, endometrial cancer, first line, immunotherapy

Data Provider: Clarivate

LINKS
-

Matching Records in NORA

SUBJECTS
+

METRICS
+